(PharmaNewsWire.Com, March 13, 2018 ) Research Analysts in Market Data Forecast has announced the addition of the “ : Global Industry Analysis and Opportunity Assessment 2016 – 2021" report to their wide spectrum research content.
Rising application of protein content determination in various fields related to pharmacy and biotechnology has stimulated the growth of the market.
Protein evaluation is an indispensable advance in the every-day work process of protein extraction in natural chemistry and atomic science that incorporates protein extraction, investigation or naming. Evaluation of proteins is vital for any example preceding confinement, while partition and examination by electrophoresis or chromatography or some other strategies. There are numerous strategies to evaluate the convergence of protein like Bradford, Lowry, BCA and UV spectroscopic Protein assays.
Almost every laboratory involved in protein research has been trying to develop several colorimetric and fluorescent, reagent-based protein assay techniques. A standard curve is compared to the increase in the fluorescence portion after the reagent is added thereby quantifying the protein content.
Major drivers for Global Proteins Assays Market include factors such as an increase in number of chronic diseases (for example infectious diseases), heavy investments in Pharmaceutical and Biological Research and Development combined with innovative technological developments and strong backing from the government in terms of funding.
Key restraints in the market include strict regulation and policy-making by local authorities, antagonistic drug reactions of unapproved drugs.
A portion of the key players ruling this market incorporate, GE Healthcare, Thermo Fisher Scientific, Biovision Inc., Merck KGaA, Lonza Group, Abcam PLC., Geno Technology Inc., Novus Biologicals, LLC., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., PerkinElmer Inc.
Regional Overview:
North America is leading the market while Europe is in second place. Growth in Pharmaceutical and biotechnological industries, strong trend of R&D in life sciences industry, increasing private-public partnership for drug development has helped these regions dominate the market. The Asia Pacific market is expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced Proteins Assays techniques.
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
